# Botox Injection in Treatment of Chronic Migraine

> **NCT02259075** · PHASE1,PHASE2 · COMPLETED · sponsor: **Norwegian University of Science and Technology** · enrollment: 10 (actual)

## Conditions studied

- Migraine Disorders

## Interventions

- **DRUG:** Botulinum Toxin Type A

## Key facts

- **NCT ID:** NCT02259075
- **Lead sponsor:** Norwegian University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2016-05-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02259075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02259075, "Botox Injection in Treatment of Chronic Migraine". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02259075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*